[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632511":3},{"organization":4,"outcomesModule":7,"designInfo":44,"detailedDescription":11,"studyPopulation":11,"armGroups":49,"interventions":56,"overallOfficials":11,"centralContacts":65,"locations":71,"responsibleParty":88,"collaborators":11,"id":90,"slug":11,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":11,"eligibilityCriteria":95,"healthyVolunteers":91,"sex":96,"minAge":97,"maxAge":98,"enrollmentInfo":99,"targetDuration":11,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":74,"whyStopped":11,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":11},[9,13,16],{"measure":10,"description":11,"timeFrame":12},"The incidence of postoperative complications",null,"After undergoing treatment for 2 months",{"measure":14,"description":11,"timeFrame":15},"Incidence rate of adverse events","Two month after the treatment",{"measure":17,"description":11,"timeFrame":18},"The VAS score within 0-72 hours after the operation","Within 3 days after receiving treatment",[20,24,27,30,33,37,39,42],{"measure":21,"description":22,"timeFrame":23},"Changes in biochemical indicators and inflammatory indicators","The unit of C-reactive protein is mg\u002FL;The unit of WBC is ×109\u002FL","One week after the treatment",{"measure":25,"description":26,"timeFrame":23},"The time of first flatus and defecation after surgery, and the time to get out of bed for activities","The time of the first postoperative standing up for activities, passing gas, and having a bowel movement is calculated in days. The postoperative hospital stay is also calculated.",{"measure":28,"description":29,"timeFrame":12},"Postoperative hospital stay and hospitalization costs","The postoperative hospital stay is calculated in days, and the hospitalization expenses are settled in RMB.",{"measure":31,"description":32,"timeFrame":18},"Postoperative analgesia satisfaction scores of the subjects and the satisfaction scores of the study doctors after the administration of the medication were obtained.","The postoperative pain relief satisfaction score and the doctor satisfaction score are calculated on a scale of 0 to 10, with 10 being the highest score.",{"measure":34,"description":35,"timeFrame":36},"The initial pressing time of the postoperative analgesic pump, the total number of presses, and the number of effective presses","The number of presses of the postoperative analgesic pump should be recorded based on the actual situation. Each press is counted as 1.","One day after the treatment",{"measure":38,"description":11,"timeFrame":12},"The time for discontinuing postoperative analgesics",{"measure":40,"description":11,"timeFrame":41},"The proportion and duration of VAS scores ≤ 3 points within 0-12 hours and 0-24 hours after the first postoperative administration","Within one day after receiving treatment",{"measure":43,"description":11,"timeFrame":12},"The timing and dosage of remedial analgesia",{"allocation":45,"interventionModel":46,"interventionModelDescription":11,"primaryPurpose":6,"observationalModel":11,"timePerspective":11,"maskingInfo":47},"NA","SINGLE_GROUP",{"masking":48,"maskingDescription":11,"whoMasked":11},"NONE",[50],{"label":51,"type":6,"description":52,"interventionNames":53},"experimental group","Postoperatively, administer Anrikefon injection intravenously at a dose of 1 μg\u002Fkg every 8 hours for three consecutive days.",[54,55],"Drug: Experimental Group","Drug: Anrikefon",[57,61],{"type":58,"name":59,"description":52,"armGroupLabels":60,"otherNames":11},"DRUG","Experimental Group",[51],{"type":58,"name":62,"description":63,"armGroupLabels":64,"otherNames":11},"Anrikefon","Postoperatively, intravenous injection of Anrikefon injection was administered at a dose of 1 μg\u002Fkg, every 8 hours, for three consecutive days as an intervention",[51],[66],{"name":67,"role":68,"phone":69,"phoneExt":11,"email":70},"yudong QIU","CONTACT","0086+13809021967","yudongqiu510@163.com",[72],{"facility":73,"status":74,"city":75,"state":11,"zip":11,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"NanJing drum tower hospital","RECRUITING","Nanjing","China","CN",{"type":79,"coordinates":80},"Point",[81,82],118.77778,32.06167,{"lat":82,"lon":81},[85,86],{"name":67,"role":68,"phone":69,"phoneExt":11,"email":70},{"name":11,"role":68,"phone":11,"phoneExt":11,"email":87},"1808456151@qq.com",{"type":89,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100632511",false,"NCT07514637","Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg\u002FKgevery 8 Hours for Three Consecutive Days After Surgery.","The Safety and Efficacy of Aniracetamfen for Postoperative Analgesia and Rehabilitation After Pancreaticoduodenectomy: A Single-center, Single-arm Clinical Study","Inclusion Criteria:\n\n* Patients who underwent pancreatic surgery, including pancreaticoduodenectomy (PD), pancreatic-preserving pancreaticoduodenectomy (PPPD), and laparoscopic pancreaticoduodenectomy (LPD)\n* Age ≥ 18 years old and \\\u003C 80 years old\n* ASA Ⅰ-Ⅲ\n* Be able to clearly understand and voluntarily participate in the research\n\nExclusion Criteria:\n\n* Merging severe primary diseases involving the heart, brain, liver, kidneys and hematopoietic system\n* History of long-term use of psychotropic drugs and cognitive dysfunction\n* Having a history of acute poisoning from alcohol, sleeping pills, painkillers or other drugs that affect the central nervous system\n* Pregnancy or lactation period\n* History of allergy to NSAIDs, opioids, or to the test medication\n* Drug users, alcoholics, and opiate abusers\n* Those who had a history of chronic pain before the operation and a history of long-term use of analgesics and\u002For sedatives\n* Those who had thyroid dysfunction before the operation","ALL","18 Years","80 Years",{"count":100,"type":101},35,"ESTIMATED","INTERVENTIONAL",[104],"PHASE2","Exploring the effectiveness and safety of early use of Ariceptinfen after pancreaticoduodenectomy in alleviating postoperative pain and promoting recovery of patients.\n\nMain objective: To explore the analgesic effect of Anricfen after pancreaticoduodenectomy.\n\nSecondary objective: To explore the impact of Anricfen on the accelerated recovery after pancreaticoduodenectomy.\n\nExploratory objective: To investigate the biomarkers of Anricfen's analgesic effect after pancreaticoduodenectomy, as well as its correlation factors with tumor pathology.",[107],"Patients Who Undergo Pancreaticoduodenectomy",[109,110,111,112],"pancreaticoduodenectomy","Peripheral κ receptor agonist","analgesia","Promote recovery","2026-04-01",{"date":115,"type":116},"2026-04-07","ACTUAL",{"date":118,"type":116},"2025-11-25",{"date":120,"type":101},"2026-03-31",{"name":5,"class":6},1]